NeoGenomics (NEO) Earnings Date, Estimates & Call Transcripts $9.58 -0.41 (-4.10%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$9.58 0.00 (0.00%) As of 03/3/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NeoGenomics Latest Earnings SummaryUpcoming Q1 Earnings DateApr. 29Before Market OpensEstimatedActual EPS (Feb. 18) -$0.02 Missed By -$0.05 Consensus EPS (Feb. 18) $0.03 NeoGenomics released Q4 2024 earnings on February 18, 2025, reporting an EPS of -$0.02, which missed analysts' consensus estimates of $0.03 by $0.05. Quarterly revenue was reported to be $172 million, below analysts' expectations of $173.40 million. With a trailing EPS of -$0.62, NeoGenomics' earnings are expected to grow next year, from ($0.20) to $0.09 per share. Conference CallConference Call TranscriptNEO Upcoming EarningsNeoGenomics' next earnings date is estimated for Tuesday, April 29, 2025, based off prior year's reporting schedules. Get NeoGenomics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeoGenomics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNEO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NEO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. NeoGenomics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252-$0.07-$0.03-$0.05 Q2 20252-$0.03-$0.02-$0.03 Q3 20252-$0.01$0.00-$0.01 Q4 20252-$0.01$0.01$0.00 FY 20258-$0.12-$0.04-$0.08 Q1 20262$0.00$0.00$0.00 Q2 20262$0.01$0.04$0.03 Q3 20262$0.02$0.04$0.03 Q4 20262$0.02$0.04$0.03 FY 20268$0.05$0.12 $0.09 NeoGenomics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/29/2025(Estimated)-------2/18/2025Q4 2024$0.03-$0.02 -$0.05-$0.12$173.40M$172.00M11/5/2024Q3 2024$0.01$0.05+$0.04$0.10$167.00M$167.80M7/29/2024Q2 2024-$0.0020$0.03+$0.0320$0.07$161.82M$164.50M4/30/2024Q1 2024-$0.07-$0.08 -$0.01$0.05$149.82M$156.24M2/20/2024Q4 2023-$0.07-$0.02+$0.05$0.07$152.90M$155.55M11/6/2023Q3 2023-$0.11-$0.06+$0.05$0.03$142.15M$151.95M8/8/2023Q2 2023-$0.15-$0.09+$0.06$0.01$138.22M$146.92M5/8/2023Q1 2023-$0.16-$0.13+$0.03-$0.01$126.31M$137.22M NeoGenomics Earnings - Frequently Asked Questions When is NeoGenomics's earnings date? NeoGenomics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based off last year's report dates. Learn more on NEO's earnings history. What guidance has NeoGenomics issued on next quarter's earnings? NeoGenomics updated its FY 2025 earnings guidance on Wednesday, January, 15th. The company issued revenue guidance of $735.0 million-$745.0 million, compared to the consensus revenue estimate of $727.9 million. Did NeoGenomics beat their earnings estimates last quarter? In the previous quarter, NeoGenomics (NASDAQ:NEO) missed the analysts' consensus estimate of $0.03 by $0.05 with a reported earnings per share (EPS) of ($0.02). Learn more on analysts' earnings estimate vs. NEO's actual earnings. How can I listen to NeoGenomics's earnings conference call? The conference call for NeoGenomics's latest earnings report can be listened to online. Listen to Conference Call How can I read NeoGenomics's conference call transcript? The conference call transcript for NeoGenomics's latest earnings report can be read online. Read Transcript How much revenue does NeoGenomics generate each year? NeoGenomics (NASDAQ:NEO) has a recorded annual revenue of $660.57 million. How much profit does NeoGenomics generate each year? NeoGenomics (NASDAQ:NEO) has a recorded net income of -$87.97 million. NEO has generated -$0.62 earnings per share over the last four quarters. What is NeoGenomics's EPS forecast for next year? NeoGenomics's earnings are expected to grow from ($0.20) per share to $0.09 per share in the next year. More Earnings Resources from MarketBeat Related Companies Etsy Earnings Date Lyft Earnings Date QXO Earnings Date Remitly Global Earnings Date Amentum Earnings Date MARA Earnings Date Frontdoor Earnings Date DLocal Earnings Date Alight Earnings Date Payoneer Global Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? This page (NASDAQ:NEO) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
